1. Home
  2. SCLX vs BEEM Comparison

SCLX vs BEEM Comparison

Compare SCLX & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

N/A

Current Price

$4.90

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Logo Beam Global

BEEM

Beam Global

N/A

Current Price

$1.37

Market Cap

28.6M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
SCLX
BEEM
Founded
2011
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
28.6M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
SCLX
BEEM
Price
$4.90
$1.37
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$3.50
AVG Volume (30 Days)
36.4K
1.5M
Earning Date
04-10-2026
04-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
40.77
EPS
N/A
N/A
Revenue
$30,253,000.00
$28,236,000.00
Revenue This Year
$122.52
$40.48
Revenue Next Year
$186.30
$32.17
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.20
$0.97
52 Week High
$34.27
$4.04

Technical Indicators

Market Signals
Indicator
SCLX
BEEM
Relative Strength Index (RSI) 27.24 52.09
Support Level $4.20 $1.36
Resistance Level $7.77 $1.67
Average True Range (ATR) 0.30 0.10
MACD 0.01 -0.01
Stochastic Oscillator 5.93 11.90

Price Performance

Historical Comparison
SCLX
BEEM

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About BEEM Beam Global

Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.

Share on Social Networks: